Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026

Reuters

Feb 06

Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026

Sisram Medical Ltd., through its core subsidiary Alma, participated in the IMCAS World Congress 2026 in Paris from January 29 to 31. At the event, the company highlighted its advancements in intelligent aesthetics, showcasing new clinical evidence on scar management, rejuvenation, and tattoo removal. Sisram featured presentations on multi-technology laser platforms and introduced innovations such as the Alma Hybrid platform for keloid scar management and the Harmony Bio-Boost collagen-stimulating treatment. Company leaders, including CEO Eyal Ben David and Chairman Lior Dayan, took part in scientific sessions and industry forums, reinforcing Sisram’s commitment to evidence-based, personalized aesthetic solutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN80791) on February 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2609300563"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609300563\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609300563?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 16:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609300563","market":"nz","top_or_hot":-1,"title":"Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Sisram Medical Ltd., through its core subsidiary Alma, participated in the IMCAS World Congress 2026 in Paris from January 29 to 31. At the event, the company highlighted its advancements in intelligent aesthetics, showcasing new clinical evidence on scar management, rejuvenation, and tattoo removal. Sisram featured presentations on multi-technology laser platforms and introduced innovations such as the Alma Hybrid platform for keloid scar management and the Harmony Bio-Boost collagen-stimulating treatment. Company leaders, including CEO Eyal Ben David and Chairman Lior Dayan, took part in scientific sessions and industry forums, reinforcing Sisram’s commitment to evidence-based, personalized aesthetic solutions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN80791) on February 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-06 16:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Sisram Medical Ltd., through its core subsidiary Alma, participated in the IMCAS World Congress 2026 in Paris from January 29 to 31. At the event, the company highlighted its advancements in intelligent aesthetics, showcasing new clinical evidence on scar management, rejuvenation, and tattoo removal. Sisram featured presentations on multi-technology laser platforms and introduced innovations such as the Alma Hybrid platform for keloid scar management and the Harmony Bio-Boost collagen-stimulating treatment. Company leaders, including CEO Eyal Ben David and Chairman Lior Dayan, took part in scientific sessions and industry forums, reinforcing Sisram’s commitment to evidence-based, personalized aesthetic solutions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN80791) on February 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL254rtH:1","article_id":"2609300563","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609300563","pubTimestamp":1770366616,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sisram Medical Ltd., through its core subsidiary Alma, participated in the IMCAS World Congress 2026 in Paris from January 29 to 31. At the event, the company highlighted its advancements in intelligent aesthetics, showcasing new clinical evidence on scar management, rejuvenation, and tattoo removal. Sisram featured presentations on multi-technology laser platforms and introduced innovations such as the Alma Hybrid platform for keloid scar management and the Harmony Bio-Boost collagen-stimulating treatment. Company leaders, including CEO Eyal Ben David and Chairman Lior Dayan, took part in scientific sessions and industry forums, reinforcing Sisram’s commitment to evidence-based, personalized aesthetic solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inve","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技","BK1593":"医美概念股","00656":"复星国际","BK1585":"昨日强势股","BK1230":"工业集团企业","BK1100":"医疗保健设备"},"translate_title":"Sisram Medical在2026年IMCAS世界大会上展示智能美学创新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":0.9,"00656":0.9},"content_text":"Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026\n    \n\n        Sisram Medical Ltd., through its core subsidiary Alma, participated in the IMCAS World Congress 2026 in Paris from January 29 to 31. At the event, the company highlighted its advancements in intelligent aesthetics, showcasing new clinical evidence on scar management, rejuvenation, and tattoo removal. Sisram featured presentations on multi-technology laser platforms and introduced innovations such as the Alma Hybrid platform for keloid scar management and the Harmony Bio-Boost collagen-stimulating treatment. Company leaders, including CEO Eyal Ben David and Chairman Lior Dayan, took part in scientific sessions and industry forums, reinforcing Sisram’s commitment to evidence-based, personalized aesthetic solutions.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN80791) on February 06, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}